KALVISTA PHARMACEUTICALS INC's ticker is KALV and the CUSIP is 483497103. A total of 90 filers reported holding KALVISTA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $118,353 | +10.9% | 12,290 | +3.7% | 0.00% | 0.0% |
Q2 2023 | $106,677 | +14.9% | 11,853 | +0.3% | 0.00% | 0.0% |
Q1 2023 | $92,858 | +18.6% | 11,814 | +2.0% | 0.00% | 0.0% |
Q4 2022 | $78,274 | -53.7% | 11,579 | -0.4% | 0.00% | 0.0% |
Q3 2022 | $169,000 | +49.6% | 11,621 | +1.4% | 0.00% | 0.0% |
Q2 2022 | $113,000 | -31.1% | 11,456 | +3.0% | 0.00% | 0.0% |
Q1 2022 | $164,000 | +4.5% | 11,119 | -6.6% | 0.00% | 0.0% |
Q4 2021 | $157,000 | -17.4% | 11,901 | +9.4% | 0.00% | 0.0% |
Q3 2021 | $190,000 | -28.8% | 10,880 | -2.3% | 0.00% | 0.0% |
Q2 2021 | $267,000 | -6.3% | 11,139 | +0.3% | 0.00% | 0.0% |
Q1 2021 | $285,000 | +77.0% | 11,105 | +30.9% | 0.00% | 0.0% |
Q4 2020 | $161,000 | +56.3% | 8,486 | +4.1% | 0.00% | – |
Q3 2020 | $103,000 | +2.0% | 8,154 | -2.2% | 0.00% | – |
Q2 2020 | $101,000 | +77.2% | 8,340 | +11.6% | 0.00% | – |
Q1 2020 | $57,000 | -59.6% | 7,472 | -5.5% | 0.00% | -100.0% |
Q4 2019 | $141,000 | +64.0% | 7,903 | +7.2% | 0.00% | – |
Q3 2019 | $86,000 | -47.6% | 7,371 | -0.7% | 0.00% | -100.0% |
Q2 2019 | $164,000 | – | 7,421 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Stonepine Capital Management, LLC | 422,310 | $10,849,000 | 5.86% |
COMMODORE CAPITAL LP | 214,467 | $5,510,000 | 2.20% |
Vivo Capital, LLC | 1,863,296 | $47,868,000 | 1.68% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 214,533 | $5,486,000 | 1.45% |
Nicholas Investment Partners, LP | 594,130 | $15,263,000 | 1.06% |
Altium Capital Management LP | 128,130 | $3,292,000 | 0.91% |
Affinity Asset Advisors, LLC | 100,000 | $2,569,000 | 0.87% |
SILVERARC CAPITAL MANAGEMENT, LLC | 50,000 | $1,285,000 | 0.70% |
APIS CAPITAL ADVISORS, LLC | 30,000 | $771,000 | 0.70% |
Birchview Capital, LP | 40,000 | $1,028,000 | 0.61% |